Similarly, wogonin (20–60 μM) inhibited the growth of breast cancer MCF-7 cells resistant to doxorubicin in a dose-dependent manner by decreasing Nrf2 protein levels in the nucleus and reducing the production of Nrf2-dependent gene HO-1 [214]. The gene discussed is NFE2L2; the disease is breast carcinoma.